A detailed history of State Street Corp transactions in Annexon, Inc. stock. As of the latest transaction made, State Street Corp holds 3,841,879 shares of ANNX stock, worth $19.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,841,879
Previous 1,773,585 116.62%
Holding current value
$19.8 Million
Previous $8.69 Million 161.71%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.49 - $7.2 $9.29 Million - $14.9 Million
2,068,294 Added 116.62%
3,841,879 $22.7 Million
Q2 2024

Aug 14, 2024

BUY
$4.33 - $6.79 $2.49 Million - $3.91 Million
575,462 Added 48.03%
1,773,585 $8.69 Million
Q1 2024

May 15, 2024

BUY
$4.03 - $7.81 $1.42 Million - $2.75 Million
351,849 Added 41.58%
1,198,123 $8.59 Million
Q4 2023

Feb 14, 2024

BUY
$1.63 - $4.63 $24,009 - $68,199
14,730 Added 1.77%
846,274 $3.84 Million
Q3 2023

Nov 14, 2023

BUY
$2.13 - $3.84 $79,449 - $143,232
37,300 Added 4.7%
831,544 $1.96 Million
Q2 2023

Aug 14, 2023

BUY
$2.1 - $6.37 $1.34 Million - $4.07 Million
638,445 Added 409.79%
794,244 $2.8 Million
Q1 2023

May 15, 2023

BUY
$3.74 - $7.46 $120,802 - $240,958
32,300 Added 26.15%
155,799 $599,000
Q4 2022

Feb 14, 2023

BUY
$4.56 - $6.61 $131,601 - $190,764
28,860 Added 30.49%
123,499 $638,000
Q3 2022

Nov 15, 2022

BUY
$3.75 - $6.63 $21,750 - $38,454
5,800 Added 6.53%
94,639 $585,000
Q2 2022

Aug 15, 2022

SELL
$2.11 - $4.06 $986,013 - $1.9 Million
-467,305 Reduced 84.03%
88,839 $335,000
Q1 2022

May 16, 2022

SELL
$2.73 - $11.94 $2.01 Million - $8.81 Million
-738,038 Reduced 57.03%
556,144 $1.52 Million
Q4 2021

Feb 14, 2022

BUY
$11.49 - $22.0 $9.07 Million - $17.4 Million
789,539 Added 156.45%
1,294,182 $14.9 Million
Q3 2021

Nov 15, 2021

SELL
$16.35 - $23.4 $7.06 Million - $10.1 Million
-432,027 Reduced 46.12%
504,643 $9.39 Million
Q2 2021

Aug 16, 2021

BUY
$17.81 - $27.48 $3.18 Million - $4.91 Million
178,578 Added 23.56%
936,670 $21.1 Million
Q1 2021

May 17, 2021

BUY
$22.0 - $35.01 $11 Million - $17.5 Million
499,198 Added 192.82%
758,092 $21.1 Million
Q4 2020

Feb 16, 2021

BUY
$20.81 - $30.55 $1.6 Million - $2.36 Million
77,116 Added 42.42%
258,894 $6.48 Million
Q3 2020

Nov 10, 2020

BUY
$17.5 - $30.23 $3.18 Million - $5.5 Million
181,778 New
181,778 $5.5 Million

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $246M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.